A novel vaccine evaluation platform to support SARS-CoV-2 vaccine development in resource-limiting settings
Implementing Organization
National Institute of Immunology (NII)
Principal Investigator
Dr Nimesh Gupta
Scientist
|
National Institute of Immunology (NII)
About
This study is focused on developing a platform for vaccine evaluation in resource-limiting settings, and developing the SARS-CoV-2 pseudovirus system against both the parental strain and variants of concerns.
Patents
NA
Achievements
NA
Outcome / Output
Knowledge on animal model for pre-clinical vaccine evaluation and the tools for vaccine efficacy assessment like SARS-CoV-2 pseudovirus and Tfh-tetramer.
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.